entertainment -WSS

entertainment

author：knowledge 2025-08-04 12:36:01 - browse：4663

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： STAT Summit: Meghan O’Rourke on making chronic illness visible

WSS

ADCs take center stage as promising cancer treatments

How the messy conversation about Dolly changed bioethics

People with substance use disorder deserve online privacy

Smaller biotechs seek to piggyback on weight loss drug boom

UnitedHealth, Optum discontinue NaviHealth name

FDA clears Verve to begin U.S. study of gene

entertainment

entertainment

hotspot

At least 13 dead in Texas as scorching temps continue

STAT Summit: Meghan O’Rourke on making chronic illness visible

BioMarin wins approval for gene therapy to treat hemophilia A

STAT Summit: The economic case for universal basic health care

Guidelines to prevent youth baseball injuries need more muscle

UnitedHealth, Optum discontinue NaviHealth name

DIEP, the 'gold standard' of breast reconstruction, is under threat

Is there really a nursing shortage in the U.S.?

ChatGPT in medicine: STAT answers readers' burning questions

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

hotspot

STAT Summit: The economic case for universal basic health care

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

White House Covid adviser calls on docs to combat misinformation

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Roche drug slashes death risk in early

Eli Lilly CEO gives to Mike Pence presidential super PAC

hotspot

focus

Wikipedia

hotspot